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Abstract Matrix-assisted laser desorption/ionization (MALDI) is now a mature
method allowing the identification and, more challenging, the quantification of
biopolymers (proteins, nucleic acids, glycans, etc). MALDI spectra show mostly
intact singly charged ions. To obtain fragments, the activation of singly charged
precursors is necessary, but not efficient above 3.5 kDa, thus making MALDI
MS/MS difficult for large species. In-source decay (ISD) is a prompt fragmentation
reaction that can be induced thermally or by radicals. As fragments are formed in
the source, precursor ions cannot be selected; however, the technique is not limited
by the mass of the analyzed compounds and pseudo MS3 can be performed on
intense fragments. The discovery of new matrices that enhance the ISD yield,
combined with the high sensitivity of MALDI mass spectrometers, and software
development, opens new perspectives. We first review the mechanisms involved in
the ISD processes, then discuss ISD applications like top-down sequencing and
post-translational modifications (PTMs) studies, and finally review MALDI-ISD
tissue imaging applications.
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CHCA a-Cyanohydroxycinnamic acid
CID Collision induced dissociation
1,5-DAN 1,5-Diaminonaphthalene
2,5-DHB 2,5-Dihydroxybenzoic acid
ECD Electron capture dissociation
ED Edman degradation
ETD Electron transfer dissociation
(HP)LC High performance liquid chromatography
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The field of biopolymer analysis has evolved considerably over the past 10 years
[1]. A major example is the explosion of “omics” techniques. Mass spectrometry
has had a major impact resulting from the continuous development of MS-based
methodologies, including instrumentation and comprehensive strategies for the
identification and quantification of a large number of molecules during a single
experiment [2–4]. The next challenge is their localization in biological samples
with their simultaneous identification and quantification.
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Matrix-assisted laser desorption/ionization (MALDI) played a large part in these
developments [5]. In UV-MALDI, the energy of a laser pulse is dissipated by a
UV-absorbing matrix containing the analytes and a dense gas phase is produced
(plume) from which intact ions survive. The primary mechanisms are not yet fully
understood but probably consist of mixed processes involving photo-excitation,
collision-induced desolvation of clusters, and gas phase acid–base chemistry
leading to charge transfer. The role of the MALDI matrix is crucial to enhance
the ion signal, and besides “general purpose” matrices, specific matrices are
adapted for various families of analytes [6]. Matrices have been classified as hot
or cold according to the internal energy transferred to the analytes, and many papers
describe methods to study the energetics and kinetics of the MALDI process [7].
Among important processes, gas phase reactions can increase the internal energy of
ions by their exothermicity. In contrast, multiple gas phase collisions have a cooling
effect [8]. The balance between these processes will govern the final energy state of
the ion population, and therefore the fragmentation rate constants and the resulting
mass spectra. If fragmentation occurs in the source, the ions will be detected at their
expected m/z values. The decay of this population of ions is called in-source decay
(ISD). When the fragmentation reaction is too slow to occur in the source but
fast enough to occur before detection, the ions are called metastable and the decay
of their population is called post-source decay (PSD) [9]. Dedicated methods of
detection are required [10].
Two major strategies rely on mass spectrometry in biopolymer analysis – the
classical bottom-up approach and the top-down strategy. In the “bottom-up”
approach, biopolymers are first digested into oligomers. In the case of proteins,
the sample preparation consists of the reduction of the disulfide bridges, followed
by alkylation of the sulfhydryl groups and an enzymatic digestion. The resulting
mix of peptides is then analyzed by MALDI. If the sample is complex, a 2D
gel separation is performed. This method is known as PMF for “peptide-mass
fingerprinting”. It can be followed by MS/MS for sequencing the peptides using
PSD to increase the identification score. Another mass spectrometric approach
commonly employed to sequence proteins is “top-down” sequencing (TDS) [11].
This strategy generally relies on the direct fragmentation of the intact protein in the
gas-phase, i.e., without any enzymatic digestion before mass spectrometry. The fact
that the whole sequence is accessible to fragmentation is one of its major
advantages. TDS is usually performed on multiply charged ions generated from
electrospray ion sources. Fragmentations occur by collision induced dissociation
(CID), by electrons as in electron capture dissociation (ECD) [6, 12, 13], or by
electron transfer dissociation (ETD) [14]. Until recently, TDS was not intensively
used with MALDI due to the fact that the produced ions are singly charged and
MS/MS techniques available on MALDI mass spectrometers are efficient only for
peptides up to m/z 3,500 [12]. Indeed, PSD and CID fragmentation processes rely
on a slow increase of the ion internal energy by multiple collisions with gas
molecules until the lower energy bonds are dissociated (mainly labile or peptide
bonds). In addition, for higher masses, the energy deposited is not sufficient to
induce dissociation. However, as the ion formation in ISD occurs before the
extraction, fragments even from large proteins receive the full kinetic energy,
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fly at their own velocity, and are detected directly at the truem/z value. The abundance
of these fragments is usually low and ISD is generally seen as an unwanted side
process and is therefore minimized. The ISD fragment nature depends on the
MALDI matrix chosen and the chemistry leading to the fragmentation.
In this chapter we will show that ISD can be a powerful structural analysis tool
when promoted by specific MALDI matrices presenting high ISD yield. The
following review is divided into three parts:
1. The description of the mechanisms leading to ISD fragmentation during the
MALDI process.Wewill describe the twomainmechanisms of ISD fragmentation
and the influence of the matrix used.
2. The description of typical MALDI-ISD spectra obtained with peptides and
proteins. We will demonstrate the interest in using MALDI-ISD to sequence
proteins as well as the limitations of this approach and the possible solutions. We
will also review the application of ISD to biopolymers.
3. The application of MALDI-ISD to tissue imaging. We describe a new
application of ISD to mass spectrometry imaging (MSI). We demonstrate that
ISD can be performed directly on a tissue slice and that the correlation between a
fragment and its localization leads to identification of different protein isoforms.
2 ISD Mechanisms
Ions produced by soft ionization methods like MALDI are generally closed
valence shell ions, which mostly undergo rearrangement type fragmentations.
These reactions are often characterized by a low activation enthalpy and a negative
activation entropy. Under low energy activation conditions, they give access to low
energy fragmentation channels. Fast thermal activation can be achieved when
sufficient energy is transferred from the matrix (hard matrices) but fast reactions
have also been shown to occur through radical chemistry. Recently, new matrices
able to release hydrogen radicals upon laser irradiation have been developed
showing an increase in the yield of ISD fragments [15].
Mechanistically, ISD is not yet fully understood. InMALDI, the prompt in-source
fragmentation can have two origins – thermal or chemical activation. Once the laser
energy is dissipated into the matrix, a “plume” containing intact ions is produced [6].
Several phenomena can then occur, such as the fragmentation of matrix clusters
and gas phase acid–base chemistry (proton transfer). Different matrices have been
classified as “hot” or “cold” according to the internal energy transferred to the
analytes. Chemical activation by hydrogen radicals is another mechanism inducing
a prompt “in source” fragmentation reaction [16, 17]. The matrix releases hydrogen
radicals. Radicals can react with the analyte to produce radical species that will
undergo specific fragmentation reactions. Using radical scavengers, it has been
shown that the ability of matrices to release hydrogen radicals is directly linked to
the efficiency of ISD fragmentation. The mass accuracy and resolution of reflectron
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TOF instruments allow the unambiguous observation of the isotopic distribution of
these fragments and clearly shows reduction reactions to occur.
The balance between thermal and radical activation will govern the chemical state
(closed shell or radical) and the internal energy of the ion population, and therefore
the fragmentation channels and their respective rate constants. Interestingly, these
radical species are generated and induce fragmentations independently from the mass
of the analytes. In the case of proteins, large c-ion and z-ion series detected up to m/z
10,000 allow for fast and efficient sequencing of the N- and C-termini extremities.
The range 0 < m/z < 800 is not accessible as intense matrix signals hide both
C-terminal and N-terminal ISD fragments. This limitation can be overcome by the
use of pseudo-MS3 strategies.
A study on the internal energy build-up of benzylpyridinium ions formed in
MALDI revealed that fragmentation can be due to thermal activation, and the
effective temperatures were estimated [17]. It has been proposed that the
exothermicity of acid–base reactions can lead to an internal energy increase [6].
The ion’s initial velocity is directly proportional to the rate of dissipation of the
plume [13, 17]. Thus, matrices characterized by a low exothermicity of acid–base
reaction and by a high initial velocity are usually colder because the analytes have
less probability of interacting with the rest of the plume.
ISD-suitable MALDI matrices revived interest in using the ISD for the de novo
sequencing of peptides and proteins [18, 19]. Indeed, ISD experiments can
be realized on all MALDI-TOF mass spectrometers, widely available in mass
spectrometry laboratories and in proteomics facilities, just by using a suitable matrix.
Sakakura et al. recently used the 5-aminosalicylic acid matrix (5-ASA) and
demonstrated that this matrix is more efficient than the classical 2,5-DHB to produce
c- and z-fragments [20]. However, this matrix remains less efficient than the 1,5-DAN
matrix and rather difficult to use (low solubility) but possesses the advantage of
being non-carcinogenic. Very recently, two additional molecules were shown to
induce radical-induced fragmentation of peptides and proteins – 2-aminobenzoic
acid (2-AA, also known as anthranilic acid) and 2-aminobenzamide (2-AB) [21].
The 1,5-DAN matrix mainly leads to (1) a radical mediated fragmentation
pathway, leading to the formation of c- and z-fragments that can be fully annotated
(C0 and Z0) and (2) a thermal activation induced by the laser irradiation, and mediated
by the matrix which leads mainly to CID-like y-, a-, and b-fragments. In some cases,
the very useful d- and w-type fragments are also observed [15]. These latter imply a
side-chain loss whose mass depends on the amino acid residue and can therefore be
useful to confirm a residue determined by two consecutive c- or z-fragments or even
to distinguish the isobaric amino acid residues leucine and isoleucine [22]. Bache
et al. have demonstrated that ISD fragmentation occurs with a low level of hydrogen
scrambling, conserving the solution deuteration pattern in the gas phase fragments
formed. This fragmentation technique could therefore be applied to hydrogen/
deuterium exchange studies of peptides and small proteins [23, 24].
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2.1 Radical-Induced Pathway
Hydrogen radicals formed by the matrix are at the origin of the formation of the
c- and z-fragments [25–27], as depicted in a mechanism proposed by Takayama [25].
In the matrix crystals, hydrogen bonds are formed between the matrix and the
analytes. During UV irradiation, a hydrogen radical transfer occurs from the matrix
to the peptide, leading to an unstable radical that is rapidly cleaved to give c- and
z-fragments (Scheme 1). z-fragments can also form adducts with a DHB molecule
to give [zþ2] þ 152 fragments using the 2,5-dihydroxybenzoic acid matrix. The
authors also conclude that the photoelectrons are involved in the ISD fragmentation
mechanism [27].
The radical-induced ISD efficiency of a matrix can be correlated to its tendency
to transfer hydrogen radicals, and this ability can be tested with hydrogen
scavengers [28, 29] such as spirooxazines [18]. The radical-induced ISD efficiency
of a matrix can also be correlated to its tendency to reduce the disulfide bond of
Scheme 1 Mechanism of the formation of radical-induced c- and z-fragments
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peptide [15] and this strategy was used by Sakakura et al. to classify 5-ASA
amongst the other ISD matrices [20].
Based on these results, a ranking of the different matrices, from the least to
the most able to transfer hydrogen radicals, was deduced: CHCA  2,5-DHB <
2-AA < 5-ASA  2-AB < 1,5-DAN. This ranking is in good agreement with the
increasing order of their radical-induced ISD abilities. Another characteristic of
radical-induced ISD is its independence from the ionization process [30]. Indeed,
Takayama et al. suggest that basic amino acids near the N-terminus favor production
of c-type fragments and basic amino acids near the C-terminus favor production of z-
and y-type fragments in positive ion mode [31, 32]. As ISD is independent of the
ionization process, radical-induced ISD fragments are also observed in the negative
ion mode according to the ability of the matrix to produce negatively charged
molecular ions. In negative mode, the 1,5-DAN matrix is far more efficient than
the 2,5-DHB matrix [15, 18]. The radical-induced fragmentation mechanism is
exactly the same in both ion modes [15].
2.2 Collisionally Activated Pathway
For the thermal pathway, the activation of the fragmentation process of peptides
occurs by a direct energy transfer from the matrix to the peptide and by collisions
with matrix molecules in the expanding MALDI plume formed following laser
irradiation [16, 17]. This thermal pathway leads to the CID-like a-, b- and y-ions
corresponding to their PSD analogs. PSD is the metastable fragmentation occurring
outside the MALDI source. This fragmentation process is activated by bimolecular
collisions with the plume components during the ion extraction. The PSD fragmen-
tation leads to the formation of the CID-like a-, b- and y-fragments.
2.3 Influence of the Matrix
The two kinds of ISD pathways are differently favored according to the matrix
used. The in-source formation of CID-like fragments by the thermal pathway has
not been widely studied [33]. Because this thermal process is caused by vibrational
activation of closed valence shell ions, the fragmentation mechanism can be
explained by the “mobile proton” model [34]. These fragments are the result of
the cleavage of the CO–NH bond that is weakened by the protonation of the
nitrogen of the amide group [35, 36]. The CID-like fragments (a-, b-, and y-type)
can then be favored by the acidity of the matrix. The 2,5-DHB matrix is then more
efficient than the 1,5-DAN matrix for production of these ions. However, it was
shown by Sachon et al. with labile peptides that the formation of these fragment
types cannot be explained only by the proton affinities of the matrices [37]. The low
energy bimolecular collisions between the peptide and the matrix can activate
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the fragmentation and are mediated by the initial axial velocity of the ions of
the MALDI plume. The lower abundance fragments issued from this pathway
using the 1,5-DAN matrix can make ISD spectra easier to interpret. Nevertheless,
use of the 1,5-DAN and 2,5-DHB matrices can be complementary to facilitate the
interpretation of ISD spectra of unknown peptides or proteins. It is noted that the
formation of CID-like fragments tends to disappear with the increasing molecular
weight of the studied compound.
2.4 Radical-Induced Pathway via Hydrogen Abstraction
Recently it was found that the oxidizing matrices 5-formylsalicylic acid and
5-nitrosalicylic acid for MALDI-ISD resulted in the generation of a and x ions by
cleavage of the Ca–C bond. MALDI-ISD with an oxidizing matrix is initiated by
hydrogen abstraction from amide portion of the peptide backbone onto the matrix,
as depicted in a mechanism proposed by Asakawa and Takayama [38, 39]. Hydro-
gen abstraction from peptides resulted in the formation of oxidized peptide
molecules [M–H]• containing a radical site on the amide nitrogen. Subsequently,
the [M–H]• radical principally generated the a and x ions, indicating cleavage of
the Ca–C bonds on the peptide backbone. However, the x ions originating from the
cleavage of the Ca–C bonds at Xxx–Pro sequences were absent, because the
Pro residue cannot have a nitrogen-centered radical site. The Ca–C bond cleavage
at Xxx–Pro and Pro–Xxx bonds would lead to a/x· and a/x fragment pairs,
respectively. The absence of x ions originating from the cleavage of the Ca–C
bonds at Xxx–Pro indicates that the fragmentation leading to an a/x·ion pair does
not occur. However, the radical fragments a·ions were not observed in MALDI-ISD
spectra with oxidizing matrix, and instead the a ions were detected. It is likely that
there are sufficient amounts of exited matrix molecules and matrix radicals in the
MALDI plume to form the a ions via further hydrogen abstraction after the Ca–C
bond cleavage. The fragmentation mechanism in MALDI-ISD with oxidizing
matrix is shown in Scheme 2a. In contrast, the cleavage of the Ca–C bond at
Xxx–Pro did not occur, and instead CO–N bond cleavage at Xxx–Pro was observed
via hydrogen abstraction from the Ca–H bond in the Pro residue. The CO–N bond
cleavage leads to the formation of the b/y fragment pair and the b·ions undergo
further degradation to form the b and a ions after the CO–N bond cleavage, as
shown in Scheme 2b [39].
3 Proteomic Applications of MALDI-ISD
3.1 MALDI-ISD and Bottom-Up Strategies
As MALDI-ISD occurs in the source, this fragmentation method does not allow
any precursor selection. In consequence, when working on enzymatic digests ISD
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signals from peptides will co-occur and the resulting overlapping spectra will
be difficult to untangle. A purification step and separation of the peptides by
LC-MALDI is thus necessary to overcome this limitation. The presence of matrix
clusters in the low m/z range (<700 Da) may also burden the observation of
low-mass fragments. Information cannot be easily obtained from this mass range,
reducing the experimental observation window. However, Reiber and Brown have
shown the possibility to sequence de novo purified small peptides in spite of matrix
adducts in the spectral low mass range [40]. The authors combined the information
coming from N-terminus (c-ions) and C-terminus (y-ions) fragments to identify six
unknown peptides. Even if the authors underlined several ambiguities in their
sequences, this approach highlights that two types of fragments can be used to
bypass the loss of information caused by the low mass matrix clusters. Another
methodology for de novo sequencing of peptides using MALDI-ISD has been
recently demonstrated by Quinton et al. [19]. The authors have used PSD and
ISD spectra in combination to determine sequences which were indecipherable by
a single fragmentation method.
Scheme 2 Mechanism of MALDI-ISD with oxidizing matrix. (a) Ca–C bond cleavage and
(b) CO–N bond cleavage at Xxx–Pro bond
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3.2 MALDI-ISD and Top-Down Strategies
MALDI-ISD appears to be a good answer to perform TDS because, as explained
above, the mechanism partially relies on a transfer of radical species and the
fragmentation process is consequently not limited by the mass. Thus, different
groups tried to sequence purified proteins spotted in sinapinic acid (SA) or
2,5-DHB. In 1995, MALDI-ISD was performed on different proteins such as
bovine cytochrome c (12.2 kDa), bovine superoxide dismutase (15.6 kDa), and
equine apomyoglobin (16.9 kDa) [41, 42]. Numerous intense c-, z-, and y- fragments
were observed between 850 m/z and 11,100 m/z. Figure 1 displays two MALDI-
ISD spectra acquired for horse heart cytochrome c (12.2 kDa) and myoglobin
(16.9 kDa). Clear c-, z-, and y-ion series are detected and lead to the characteri-
zation of 78 amino acids out of 104 for cytochrome c (75%) and 93 out of 153 for
myoglobin (61%).
These signals enable the building of long sequence tags for each protein,
which can be submitted in BLAST in order to compare them to the sequences
present in the databases and to identify the protein of interest. However, the full
sequence of the protein is not always accessible by ISD. For example, as the ISD
process leads to breaking the N–Ca bond, a proline residue cannot produce ISD
fragments due to its cyclic nature. However, this observation is predictable, and a
gap in c-ions of an ISD-sequencing experiment can be interpreted as a proline
residue on the N-side followed by another amino acid, Pro–X, the mass and
position of which in the sequence can easily be determined.
3.3 MALDI-ISD and Pseudo-MS3 Strategies
Protein ISD generally leads to an intense c-ion series and allows a precise
characterization of the N-terminus part of the protein(s). However, the full
N- and C-termini cannot be determined due to matrix background at low m/z ratios
that prevents the observation of the very first fragments. Different “pseudo-MS3”
(pMS3) strategies have therefore been imagined to describe the sequences
extremities [43, 44]. These strategies exploit the fact that an ISD fragment can be
selected and fragmented by CID like a classical ion generated by a MALDI source.
Simply, an ISD fragment (m/z < 3,500) is isolated before subjection to PSD
fragmentation. If the selected ion is a c-type, then the resulting MS/MS spectrum
will characterize the N-terminus. Similarly, if the precursor ion is a z- or a y-ion,
then the C-terminus part will be characterized. Figure 2 shows an example of
a pMS3-experiment. Aldolase protein (39.2 kDa) has been fragmented by
MALDI-ISD using 2,5-DHB. A tag of 56 consecutive amino acids has been
obtained from this single spectrum. However, as already discussed above, the
N- and the C-termini are missing. To characterize the C-terminus part, a y-ion
(y12) was then selected and fragmented. The MS/MS spectrum obtained (Fig. 2,
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bottom panel) clearly displays intense y- and b-ion types which enable an easy
characterization of the missing C-terminus part.
As the use of pMS3-sequencing allows full characterization of the protein
extremities, it constitutes a competitive methodology to replace Edman degradation
(ED). ED was the most used protein sequencer during the past few decades. First
of all, the time scale of each experiment is in favor of ISD/pMS3. Whereas ED takes
more than 30 min per amino acid, MALDI-ISD takes around 10 min from the
sample deposition to determination of a tag of several tens of amino acids.
Moreover, from tens of picomoles of purified proteins, ED allows the sequencing
of the first 50 amino acids except when the N-terminal amino acid is modified. With
Fig. 1 MALDI-ISD spectra of (a) horse heart cytochrome c (12.2 kDa) and (b) horse heart
myoglobin (16.9 kDa). One picomole of each protein was spotted onto the MALDI plate and
mixed together with 1,5-DAN saturated in FA (0.2%)/ACN. Using intense c- and z-ion series, 77%
and 61% of sequence coverage were characterized for cytochrome c and myoglobin, respectively.
C- and N-terminus extremities are missing because fragments are hidden by intense matrix signals
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the same amount of compound or even less, MALDI-ISD combined with
pMS3-sequencing gives access in the more favorable cases to the first 80 amino
acids from the N-terminus but also to the last 40 amino acids from the C-terminus.
It is important to highlight that pMS3-sequencing also works if the extremities
are modified and, thus, can reveal post-translational modifications (PTMs). The
approach of combining ISD and pMS3 has recently been highlighted by Resemann
et al. [45]. In this work, the authors demonstrated the ability of MALDI-TDS to
sequence fully a Camelid single heavy chain antibody of 13.6 kDa. The authors
indicate that larger proteins may also be sequenced by MALDI-TDS but the use of
reference sequence information in databases or complementary results from
bottom-up approaches becomes unavoidable.
3.4 MALDI-ISD and PTMs
Several teams tried to apply MALDI-ISD to the detection and localization of
PTMs. In 1997, Lennon and Walsh demonstrated that sequence determination by
MALDI-ISD was stopped near the cysteins involved in disulfide bonds or covalent
bonds to a heme molecule. These results demonstrated that the peptide
Fig. 2 Example of a pMS3 experiment on Aldolase (39.2 kDa). (a) MALDI-ISD spectra of the
protein displaying a long series of c-ions but also several y- and z-type ions. (b) y12 ion is
fragmented by post-source decay, unambiguously revealing the whole missing N-terminus
extremity
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modifications were able to interfere with the ISD promoted by DHB [42, 44].
Indeed, a disulfide bond tends to be reduced during the ISD process [46] and
therefore acts as a quencher of the fragmentation of neighboring amino acids.
This observation was exploited by Schnaible et al. to localize disulfide bonds on
HPLC-separated peptides [47, 48]. Moreover, PTMs that do not interfere with the
ISD fragmentation of the peptide backbone can be studied by ISD as well. For
example, Lennon et al. demonstrated in 1999 that labile modifications such as
serine phosphorylations were not affected by the ISD process [49]. These PTMs
can therefore be characterized either by a direct MALDI-ISD experiment or after a
pMS3-sequencing methodology [50].
Concerning glycosylation, MALDI-ISD was applied both on glycoproteins/
glycopeptides and on isolated glycans. Collisionally-induced MALDI-ISD of
glycopeptides led to the observation of both glycan and peptide fragmentations
[51]. On the other hand, radical-induced ISD allowed Hanisch sequencing
glycoproteins and localizing O-glycosylation sites, confirming again the ability of
this technique to preserve labile PTMs [52]. However, Chaurand et al. observed that
N-glycosylation was able to stop the protein sequencing, allowing localization of
this PTM, but not further sequencing [53]. These contradictory results suggest a
potential effect of the carbohydrate moiety on the sequencing of the glycoproteins.
As glycans can be easily isolated and purified, the ISD and pMS3-sequencing
approaches were also employed to characterize thoroughly the structures of both
native [43, 54–60] and permethylated glycans [61–66], allowing unambiguous
discrimination of isobaric species. In ref. [64] it was also mentioned that 6-aza-2-
thiothymine (ATT) was able to promote ISD fragmentation of permethylated
glycans. The mechanism involves in this case the protonation of the permethylated
glycan, leading to its fragmentation. In addition, 2,5-DHB could act as a dual matrix
here, allowing ISD of permethylated glycans when laser shots are made on crystals
(where protons are available) but impeding ISD when laser shots are made in
the central amorphous zone of the spots. Indeed, this part is sodium-rich and
protonation is therefore unfavored compared to cationization [67].
Other classical PTMs such as pyroglutamic acid [53], formylation [68],
deamidation [44], and acetylation [2] have also been described and studied by
MALDI-ISD. Finally, Yoo and collaborators showed recently that MALDI-ISD
was also an appropriate tool to localize PEGylation of protein [69], which is a
chemical modification widely employed in the pharmaceutical field [70].
In conclusion, MALDI-ISD can be employed in a wide panel of applications
such as the characterization of recombinant proteins, the full de novo sequencing of
unknown proteins, and the localization of PTMs.
3.5 MALDI-ISD of Oligonucleotides
Besides peptides and proteins, substantial work was also achieved in order to use
ISD to sequence oligonucleotides. In 1995, Nordhoff et al. reported the prompt
fragmentation of oligonucleotides in an IR-MALDI source [71] while Zhu et al.
used 2,5-DHB to induce in-source fragmentation in a UV-MALDI source [71, 72].
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Following these observations, delayed extraction was applied and sequencing of an
11-mer DNA was achieved using a 266 nm laser with picolinic acid as matrix [73].
According to the McLuckey nomenclature [74], mainly w-type ions (resulting from
the cleavage of a phosphodiester bond and containing a 50-terminal phosphate group)
were observed. A base loss is considered to be a critical step of this “thermal”
fragmentation pathway [75, 76]. Alternatively, a pathway of electronic energy
transfer was also proposed to occur in positive ion mode with 2-aminobenzoic acid
and leads to the formation of supplementary ions (d-, b-, and y-ions) [77]. Concerning
applications of ISD in the nucleic acids field, ISD was successfully applied by Wang
et al. to sequence covalently modified (phosphorothioate instead of phosphodiester
bonds) oligonucleotides [78] but failed to allow locating covalent rhodium adducts on
DNA [79].
4 MALDI Mass Spectrometry Imaging
MALDI-MSI is a powerful technique that allows mapping of many classes of
compounds directly from a tissue slice of several micrometers thickness. The
principle of MALDI-MSI relies on a pixelization of the surface to be analyzed. A
mass spectrum is recorded at each pixel, providing a triplet of information (spatial
coordinates, mass, and intensity of the peak) for each signal present in the mass
spectrum. Accumulating and integrating these data allows building a 2D cartography
for any detected molecule, without the need for previous knowledge of the molecular
content of the sample. On the image, the intensity of the signal is depicted by a
color scale.
MALDI-MSI is suitable for high molecular weight biomolecules (proteins) but
also for small molecules such as lipids, drugs, and their metabolites, etc. In most
published applications, proteins are targeted as potential biomarkers of pathology,
as in many studies, for ovarian tumors [80, 81], renal carcinoma [82], or
Parkinson’s disease [83, 84]. For small molecules analysis, two main classes
may be distinguished – exogenous drugs and endogenous metabolites. Exogenous
drugs have been studied in MALDI-MSI far later than proteins (since 2004)
for different targets such as olanzapine (antipsychotic) [85–87], imatinib [87],
vinblastine [88], and banoxantrone [89] (cancer drugs). Among endogenous
metabolites, lipids such as glycerophospholipids and glycosphingolipids or simple
lipids like cholesterol, diacylglycerols, or triacylglycerols have been extensively
investigated [90]. Also studied are primary metabolites (ADP, ATP, . . .) as targets
for MALDI-MSI [91].
Concerning MALDI-MSI, a lot of work has been done to improve the
experimental workflow, such as optimization of sample preparation and matrix
deposition [92], and much focus has been on the identification of the detected
molecules. When small molecules are analyzed, the identification is rather straight-
forward where tandem mass spectrometry can be easily used, leading to the
fragmentation of the detected compounds, allowing their unambiguous
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characterization. The identification is even more reliable when high resolution
exact mass measurements can be performed. If proteins are analyzed, it is rather
difficult to perform MS/MS analysis directly from proteins that are more difficult to
fragment and the unique information of the m/z value is not sufficient as it may
correspond to several primary sequences. To achieve protein identification, in situ
digestion has been used since 2007 [93]. This method consists of the deposition
(more often by micro-spotting or nano-spotting) of a solution of protease (usually
trypsin) at the surface of the sample, followed by 2–4 h of incubation and analysis
of the resulting mix of peptides. The classical PMF method is then used to query
protein databases for identification. Although this procedure presents some
drawbacks (need for a microspotting system to deposit the enzyme solution as
precisely as possible, time-consuming, and leads to mass spectra which can be
complex and difficult to interpret), it has been extensively used since its implemen-
tation. MALDI-ISD, however, removes the need for in situ digestion when
analyzing tissues.
4.1 MALDI-ISD on Tissue Slices
MALDI-ISD seems to be useful in this context, and Debois et al. developed an
ISD-based method for protein identification, directly from a tissue section, without
any further treatment [94]. Indeed, to be implemented, the technique requires only
the use of an “ISD-favorable” matrix such as 2,5-DHB or 1,5-DAN as already
mentioned. The analysis is then performed as a simple full scan MS acquisition,
neither requiring an increase of the laser intensity nor the number of shots on the
tissue. The resulting mass spectrum allows the creation of a sequence tag of amino
acids and the original protein may be identified thanks to a query in protein
databases, using a BLAST search.
Figure 3a shows an ISD mass spectrum recorded on a porcine eye lens with
1,5-DAN as a matrix [94]. Two ions series were detected, leading to two
different tags: QPLNPKIIIF EKENFKGHSH ELNGPCPNLK ETGVEQAGSV
and WQMDRIRRVS QVPQ, respectively. For the first tag, the interrogation of
databases led to the identification of the Beta-Crystallin B2 for three different
species (rabbit, bovine, and guinea pig). Nevertheless, some differences exist
between the primary sequences of rabbit, bovine, and guinea pig Beta-Crystallins
B2. To obtain the N-terminal sequence of the porcine Beta-Crystallin B2, a pMS3-
sequencing experiment was performed on the same tissue slice. The ion atm/z value
1,519.0 was selected and then fragmented. Figure 3b depicts the resulting MS/MS
spectrum. Almost the entire b-ions and y-ions series were obtained and the acetyla-
tion of the Ala residue was also confirmed, giving access to the full sequence of the
N-terminus part of the porcine Beta-Crystallin B2 (51 first amino acids), which is
not referenced in databases (SwissProt and TrEMBL). These results open the way
towards de novo sequencing, directly from tissue slices. The method was applied
for biomarkers discovery [95, 96].
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4.2 MALDI-ISD Imaging
ISD can also be performed during a tissue imaging experiment, allowing the
localization of different fragments to be considered. Figure 4 presents MALDI
images recorded on a porcine eye lens slice, with 1,5-DAN as the matrix [94].
Getting the distribution of ISD fragments provides two additional pieces of infor-
mation. First, it becomes easy to find which fragments are coming from the same
protein, as they all exhibit the same localization on the tissue surface. This can help
to indicate real consecutive peaks, facilitating the protein sequencing. Second, by
overlaying these images, it becomes possible to highlight high intensity pixel(s) and
Fig. 3 (a) ISD mass spectrum recorded on a porcine eye lens slice with 1,5-DAN as a matrix. The
tag and the masses indicated in green correspond to the N-terminus part of the Beta-Crystallin
B2 (c-ions series), the purple ones to the C-terminus part (z-ions series). (b) T3-sequencing
mass spectrum obtained by isolating the ion at m/z 1,519.08 and by fragmenting it by PSD.
Quasi-complete b- and y-ions series are observable, leading to the full sequencing of the
N-terminus part of the protein
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specifically extract the corresponding mass spectrum. Of course, the more intense
the mass spectrum and the more peaks present, the easier the interpretation. In
Fig. 4, for example, the three fragments exhibit close localizations, suggesting their
common origin, and the overlay of their images (Fig. 4d) shows an intense pixel
(yellow-circled) which allows the extraction of the ISD mass spectrum shown in
Fig. 4e. Two sequence tags were then established, leading to the identification of
Gamma-Crystallin B.
The ISD process is often criticized, and the main denigrations are related to the
presumed need for a pure sample, to its lower sensitivity, and to its reduced mass
accuracy and resolution. In fact, some of these criticisms are based on false
assumptions.
Fig. 4 MALDI images of ISD fragments at (a) m/z 1,214.9, (b) m/z 1,361.9, and (c) m/z 1,703.2,
recorded on a porcine eye lens slice. (d) Overlay of the three previous ion images. The black and
the yellow circles indicate the region where the mass spectrum has been extracted (high intensity
pixel). (e) ISD mass spectrum extracted from a high intensity pixel. The tag and the masses
indicated in green correspond to the N-terminus part of the Gamma-Crystallin B (c-ions series),
the purples ones to the C-terminus part (z-ions series). The green purple-framed annotation
indicates a peak for which m/z value corresponds to both c- and z-ion. The ion peaks which
images are shown are labeled with letters A, B, C
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Concerning the kind of sample that can be analyzed by ISD, it is admitted that a
tissue slice is a complex sample and that within one 50-mm-wide laser shot, several
proteins may be desorbed and fragmented. To decrease the number of analyzed
proteins, two approaches are considered. The first choice consists of decreasing the
size of the laser shot (to 30 or even 20 mm). In this case, the question is: what about
the sensitivity of the instrument? Would it be sensitive enough to obtain interpret-
able ISD mass spectra? How many molecules are present in a 20-mm-wide pixel?
And, out of these, how many will fragment? This issue has to be investigated. The
second choice for decreasing the number of analyzed proteins is to employ sample
depletion methods to remove the high abundance proteins from the tissue slice [97].
Or, rather than depleting the abundant proteins, a variety of identifications can
instead be obtained by imaging multiple yet slightly different tissue sections. Thus,
in MALDI-ISD imaging, serial sections are still likely to result in detection of the
same set of proteins, but the sensitivity of the ISD process to protein ionization
efficiencies allows a larger variety of protein identifications to be made from
slightly more different tissue sections. MALDI-ISD imaging therefore allows the
variety of proteins identified and localized between different tissue sections to
mirror more effectively the changes in sample composition. This feature of
MALDI-ISD could be used in combination with sample depletion to reveal even
more proteins.
Concerning the issue of the mass accuracy, this does not represent a severe
problem. Indeed, during the data treatment, it is not the mass of peptides which is
measured, but the mass difference between consecutive peaks that is used to obtain
an amino acid residue identification. Accurate mass of peptides is more important in
the PMF strategy where intact analyte masses are used to query protein databases,
but for sequencing a good external calibration of the mass spectrum is sufficient to
allow the mass spectrum interpretation. Moreover, to improve the quality of mass
accuracy and calibration, it is best to use ISD fragments of a known protein
(myoglobin for example) to create a calibration mass list. In this way, data used
for calibration and data coming from the sample are recorded under the same
conditions and the whole mass range is covered, far better than with a commercial
peptides mixture. For mass resolution, as mentioned previously, ISD fragments are
formed in the ionization source before the extraction of ions (contrary to PSD), then
travel through the flight tube, and with the use of an electrostatic mirror the mass
resolution obtained for ISD mass spectra is completely satisfactory.
Progress has recently occurred regarding data treatment for MALDI-ISD imaging.
In fact, MALDI-ISD imaging presents a relatively new type of dataset, wherein a
protein sequence can be found in each pixel, and this calls for the development of new
software and data analysis methods. Zimmerman et al. have created an analytical
pipeline suite of software that accomplishes two main goals: automated analysis of
MALDI-ISD “top-down” spectra for protein sequencing and automated analysis of
MALDI-ISD tissue imaging data [98]. These goals can be combined so that an
imaging dataset is first searched by the software to find groups of highly correlated
peaks that co-occur and that are likely to correspond to a single protein. Second, the
software can then identify the highest quality spectra from the imaging dataset for
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automated de novo sequencing. After a first protein is automatically sequenced or
identified, another search is run in the imaging data to find spectral patterns of
peaks that are different from that of the first sequenced protein, which are likely to
correspond either to a second protein or to a post translationally modified form of
the first protein. This semi-automated process is iterated for an exhaustive characteri-
zation all of the proteins in the MALDI-ISD imaging dataset. Ion images are
subsequently plotted by the software showing the spatial localizations of the
identified proteins over the tissue surface. The MALDI-ISD protein sequencing
software is used either in combination with imaging datasets, or to sequence proteins
from individual MALDI-ISD spectra [98–100].
As applied to individual spectra, the sequencing software uses mass differences
calculated from spectral peak lists to perform protein sequencing, and the
software is able to overcome interference due to unidentified fragmentation peaks
or redundant ion series peaks. In addition, as it was shown that ISD patterns for up
to three proteins can exist simultaneously within a single MALDI-ISD spectrum,
the software can subtract the already known ISD peak pattern of a known protein
out of the peak list. This isolates the remaining peaks, leaving the refined peak list to
be passed through the software for identification of a second protein, and by
repeating this process a third protein is identified. This analysis process for
protein mixtures is advantageous for use with MALDI-ISD tissue imaging data,
as MALDI-ISD mass peaks corresponding to more abundant proteins are likely to
be already known and can be subtracted from the spectral peak lists to simplify the
data analysis for the remaining proteins.
A future possible way to facilitate ISD analysis of complex mixtures is the
generation of all possible sequence tags that fit the data within a tolerance window.
At present it is difficult for software to interpret ISD mass spectra containing more
than two or three proteins because of the large number of peaks present. In the rarer
cases where more than three proteins exist in a single ISD spectrum, the idea is to
have the software calculate any possible tag and then automatically submit them to
query protein databases using a BLAST engine. After this first stage the user should
validate (or not) the results and the software could then create an exclusion list for
peaks already used, followed by identification of the remaining proteins. This could
be seen as a “cleaning” of the ISD mass spectrum. This future direction for
automated data treatment would greatly decrease the time needed for mass spectra
interpretation and would not necessitate the presence of the user.
5 Conclusions
MALDI-ISD seems to have a promising future and will likely have increasing
importance in mass spectrometry applications. Top-down sequencing of proteins
seems to be the most promising application. Indeed, MALDI-ISD allows a rapid
characterization of N-terminal and sometimes C-terminal sequences of a protein
and from only a few picomoles of compounds. This technique could be employed
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for the routine quality control of recombinant proteins. Another promising theme
resides in MALDI-imaging with ISD and pMS3 performed directly on tissue slices,
which could drive the characterization of different proteins and, in the best cases, of
pathological biomarkers. In parallel studies, MALDI-ISD has been performed with
success on other biopolymers including oligonucleotides and therefore can be
generalized as a fast sequencing method.
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